Madrigal Pharmaceuticals, Inc. (MDGL) Free Cash Flow
Madrigal Pharmaceuticals, Inc. (MDGL) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$17.53M |
| 2017-12-31 | -$22.44M |
| 2018-12-31 | -$25.53M |
| 2019-12-31 | -$41.80M |
| 2020-12-31 | -$157.90M |
| 2021-12-31 | -$184.13M |
| 2022-12-31 | -$225.07M |
| 2023-12-31 | -$325.71M |
| 2024-12-31 | -$462.03M |
| 2025-12-31 | -$193.02M |
How MDGL compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| RGNX | REGENXBIO Inc. | -$126.38M |
| SMMT | Summit Therapeutics Inc. | -$142.25M |
| CELC | Celcuity Inc. | -$153.53M |
| OCUL | Ocular Therapeutix Inc. | -$216.89M |
| EYPT | EyePoint Pharmaceuticals Inc. | -$243.39M |
These are five companies in the same sector as MDGL with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Madrigal Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("MDGL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MDGL | $516.74 | -0.45% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |